Browsing by Subject
Ara mostrant els elements 1-5 d 5
-
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial
(Wolters Kluwer Health, 2021-08) -
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial
(American Society of Hematology, 2023-01-12) -
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
(American Society of Clinical Oncology, 2020-12-20) -
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
(Wolters Kluwer Health, 2023-01) -
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy
(American Association for Cancer Research, 2024-02)